Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer ; volume:21 ; number:1 ; day:26 ; month:7 ; year:2023 ; pages:1-13 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (26.7.2023), 1-13, 12.2023
- Urheber
-
Tsai, Kuei-Yen
Chang, Yu-Jia
Huang, Chien-Yu
Prince, G. M. Shazzad Hossain
Chen, Hsin-An
Makondi, Precious Takondwa
Shen, Ying-Rou
Wei, Po-Li
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04363-5
- URN
-
urn:nbn:de:101:1-2023102710420671062774
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsai, Kuei-Yen
- Chang, Yu-Jia
- Huang, Chien-Yu
- Prince, G. M. Shazzad Hossain
- Chen, Hsin-An
- Makondi, Precious Takondwa
- Shen, Ying-Rou
- Wei, Po-Li
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plasma N-glycans in colorectal cancer risk
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Targeting the glycans of the HIV envelope as a therapeutic tool
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Predicting clinically promising therapeutic hypotheses using tensor factorization
Plasma N-glycans in colorectal cancer risk
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Targeting the glycans of the HIV envelope as a therapeutic tool
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Predicting clinically promising therapeutic hypotheses using tensor factorization
Plasma N-glycans in colorectal cancer risk
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Targeting the glycans of the HIV envelope as a therapeutic tool
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
Oligonucleotides—A Novel Promising Therapeutic Option for IBD